You are here: Welcome » Jessica Hopkins

Jessica Hopkins

Dr. Jessica Hopkins is employed at the Dalla Lana School of Public Health at the University of Toronto, McMaster University, and Public Health Ontario. She is also Co-Chair of the Ontario Immunization Advisory Committee (OIAC), and formerly held lead Officer positions for Hamilton and Niagara, and Peel Health Region. She is registered to practice medicine at Limeridge Medical Centre.

Affiliations

Limeridge Medical Centre

Hopkins is registered with the College of Physicians and Physicians (CPSO) to practice medicine at Limeridge Medical Centre in Hamilton, Ontario.1)

McMaster University

Hopkins is an Assistant Professor in Health Research Methods, Evidence and Impact in the Faculty of Health Sciences at McMaster University.2)

Ontario COVID-19 Science Advisory Table

Hopkins is a member of the Ontario COVID-19 Science Advisory Table.3) In this capacity, Hopkins urged parents to inject their children with a COVID-19 product as soon as they were approved by the National Advisory Committee on Immunization (NACI), as well as all of their caregivers.4)

Ontario Medical Association

Hopkins has served as a member on the Physician Services Committee of the Ontario Medical Association, for which she received “remuneration for travel and accommodation”.5)

Public Health Agency of Canada

Hopkins is a member of the Technical Advisory Committee for COVID-19 under the Public Health Agency of Canada (PHAC).6)

Public Health Ontario

Hopkins is the Chief Health Protection and Emergency Preparedness Officer at Public Health Ontario. Her listed areas of expertise are public health, communicable diseases, surveillance and epidemiology, and public health policy. Her COVID-19 research activities under PHO are “examining child and family policies”, “collaborating on understanding mask use in schools through simulation”, and “collaboration on public health syndromic surveillance using people-driven data”.7)

University of Toronto

Hopkins is an Adjunct Lecturer with the Dalla Lana School of Public Health at the University of Toronto, in the Clinical Public Health Division. Her research interests are “applied public health practice and communicable disease control”.8)

Publications

Hopkins' relevant studies featured by her profiles on U of T and McMaster’s websites include:

  • Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results.9)
    • Conclusion: “Large-scale SARS-CoV-2 screening testing initiatives among low pre-test probability populations [patients who are not symptomatic and/or don’t have a confirmed contact with a person sick with COVID-19] should be evaluated thoroughly prior to implementation given the risk of false positives and consequent potential for harm at the individual and population level.”
  • S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 202110)
  • The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada11)
  • Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy12)
  • Antivirals for Treatment of Influenza: A Systematic Review and Meta-analysis of Observational Studies13)
  • Evaluation of the ability of standardized supports to improve public health response to syndromic surveillance for respiratory diseases in Canada14)
  • World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen-and-treat strategies to prevent cervical cancer15)
1)
Hopkins, Jessica Patricia - Doctor Details. College of Physicians and Surgeons of Ontario. Retrieved December 12, 2021, from https://doctors.cpso.on.ca/DoctorDetails/Hopkins-Jessica---Patricia/0210039-80671
2)
Jessica Hopkins. McMaster University. Retrieved December 12, 2021, from https://experts.mcmaster.ca/display/hopkij1
3)
About Us. Ontario COVID-19 Science Advisory Table. Retrieved January 29, 2022, from https://covid19-sciencetable.ca/about/#hopkins-jessica
4)
Cross, J. S. (2021, August 26). Public Health Ontario urging parents to immunize young children against COVID-19 as soon as vaccines are approved. QP Briefing. https://www.qpbriefing.com/2021/08/26/public-health-ontario-urging-parents-to-immunize-young-children-against-covid-19-as-soon-as-vaccines-are-approved/
5)
Hopkins, J. (2021, August 23). Declaration of Interest. Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2020/11/Declaration-of-Interest_Science-Table_Jessica-Hopkins_20210823.pdf
6)
Hopkins, J. (2021, May 25). Declaration of Interest. Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2020/11/Declaration-of-Interest_Science-Table_Hopkins_20210525.pdf
7)
Dr. Jessica Hopkins. (2021, January 6). Public Health Ontario. https://www.publichealthontario.ca/en/about/research/our-researchers/jessica-hopkins
8)
Dalla Lana School of Public Health. (2018, June 14). Hopkins, Jessica. University of Toronto. https://www.dlsph.utoronto.ca/faculty-profile/hopkins-jessica/
9)
Gubbay, J. B., Rilkoff, H., Kristjanson, H. L., Forbes, J. D., Murti, M., Eshaghi, A., Broukhanski, G., Corbeil, A., Fittipaldi, N., Hopkins, J. P., Kristjanson, E., Kus, J. V., Macdonald, L., Majury, A., Mallo, G. V., Mazzulli, T., Melano, R. G., Olsha, R., Perusini, S. J., & Tran, V. (2021). Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results. Infection Control & Hospital Epidemiology, 1–18. https://doi.org/10.1017/ice.2021.369
10)
Brown, K. A., Gubbay, J., Hopkins, J., Patel, S., Buchan, S. A., Daneman, N., & Goneau, L. W. (2021). S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021. JAMA, 325(20), 2115. https://doi.org/10.1001/jama.2021.5607
11)
Maharaj, A. S., Parker, J., Hopkins, J. P., Gournis, E., Bogoch, I. I., Rader, B., Astley, C. M., Ivers, N., Hawkins, J. B., VanStone, N., Tuite, A. R., Fisman, D. N., Brownstein, J. S., & Lapointe-Shaw, L. (2021). The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada. The Lancet Infectious Diseases, 21(5), 593–594. https://doi.org/10.1016/s1473-3099(21)00151-1
12)
Mustafa, R. A., Santesso, N., Khatib, R., Mustafa, A. A., Wiercioch, W., Kehar, R., Gandhi, S., Chen, Y., Cheung, A., Hopkins, J., Ma, B., Lloyd, N., Wu, D., Broutet, N., & Schünemann, H. J. (2016). Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 132(3), 259–265. https://doi.org/10.1016/j.ijgo.2015.07.024
13)
Hsu, J., Santesso, N., Mustafa, R., Brozek, J., Chen, Y. L., Hopkins, J. P., Cheung, A., Hovhannisyan, G., Ivanova, L., Flottorp, S. A., Sæterdal, I., Wong, A. D., Tian, J., Uyeki, T. M., Akl, E. A., Alonso-Coello, P., Smaill, F., & Schünemann, H. J. (2012). Antivirals for Treatment of Influenza. Annals of Internal Medicine, 156(7), 512. https://doi.org/10.7326/0003-4819-156-7-201204030-00411
14)
Rivera, L. A., Li, Y., Savage, R. D., Crowcroft, N. S., Bolotin, S., Rosella, L. C., Lou, W., Hopkins, J., Gemmill, I., & Johnson, I. (2017). Evaluation of the ability of standardized supports to improve public health response to syndromic surveillance for respiratory diseases in Canada. BMC Public Health, 17(1). https://doi.org/10.1186/s12889-017-4073-6
15)
Santesso, N., Mustafa, R. A., Schünemann, H. J., Arbyn, M., Blumenthal, P. D., Cain, J., Chirenje, M., Denny, L., De Vuyst, H., Eckert, L. O., Forhan, S. E., Franco, E. L., Gage, J. C., Garcia, F., Herrero, R., Jeronimo, J., Lu, E. R., Luciani, S., Quek, S. C., & Sankaranarayanan, R. (2016). World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 132(3), 252–258. https://doi.org/10.1016/j.ijgo.2015.07.038
Back to top